NOTCH3 and neoplasm: Furthermore, elevated expression of Notch3 in NSCLC has been seen associated with poor disease outcome [12], and NSCLC cell-derived xenografts treated with GSI MRK-003 displayed marked absence of Notch3ICD, which initially was significantly overexpressed, as well as remarkable decreased tumor growth capacity [73].